Stephen Beard Sells 3,545 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Key Points

• CEO Stephen Beard sold 3,545 Adtalem shares at an average price of $130.34, totaling $462,055.30. The transaction occurred under a pre-arranged Rule 10b5-1 plan and reduced his ownership by 0.85%.
• Adtalem reported quarterly earnings of $2.09 per share, exceeding analyst expectations of $1.90, on revenue of $501.38 million. The company issued fiscal 2027 EPS guidance of $8.90–$9.15.
• Shares recently traded at $132.20, while analysts maintain a “Moderate Buy” consensus with an average price target of $155; institutional investors own 98.84% of the stock.

Adtalem Global Education Inc. (NYSE:CVSA - Get Free Report) CEO Stephen Beard sold 3,545 shares of the company's stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $130.34, for a total transaction of $462,055.30. Following the transaction, the chief executive officer owned 415,197 shares in the company, valued at $54,116,776.98. The trade was a 0.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Shares of CVSA stock traded up $3.98 during midday trading on Thursday, reaching $132.20. 267,402 shares of the company traded hands, compared to its average volume of 371,319. The business's 50 day moving average price is $125.00. Adtalem Global Education Inc. has a 1-year low of $86.97 and a 1-year high of $156.26. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45. The stock has a market cap of $4.50 billion, a price-to-earnings ratio of 18.78, a PEG ratio of 0.94 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The business had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, research analysts anticipate that Adtalem Global Education Inc. will post 8.99 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management purchased a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 11,622 shares of the company's stock, valued at approximately $1,449,000. Institutional investors own 98.84% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on CVSA shares. Barrington Research reissued an "outperform" rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Monday, June 8th. Truist Financial boosted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday, May 11th. Wall Street Zen raised shares of Adtalem Global Education from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education NYSE: CVSA is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source